HomeInsightsStock Comparison

Hester Biosciences Ltd vs Medicamen Biotech Ltd Stock Comparison

Hester Biosciences Ltd vs Medicamen Biotech Ltd Stock Comparison

Last Updated on: Jun 22, 2025

Key Highlights

  • The Latest Trading Price of Hester Biosciences Ltd is ₹ 1747 as of 20 Jun 15:30.
  • The P/E Ratio of Hester Biosciences Ltd changed from 27 on March 2020 to 62.6 on March 2024 . This represents a CAGR of 18.32% over 5 yearsThe P/E Ratio of Medicamen Biotech Ltd changed from 16.6 on March 2020 to 44.5 on March 2024 . This represents a CAGR of 21.80% over 5 years.
  • The Market Cap of Hester Biosciences Ltd changed from ₹ 786.93 crore on March 2020 to ₹ 1181 crore on March 2024 . This represents a CAGR of 8.47% over 5 yearsThe Market Cap of Medicamen Biotech Ltd changed from ₹ 220.75 crore on March 2020 to ₹ 487.1 crore on March 2024 . This represents a CAGR of 17.15% over 5 years.
  • The revenue of Hester Biosciences Ltd for the Mar '25 is ₹ 76.29 crore as compare to the Dec '24 revenue of ₹ 72 crore. This represent the growth of 5.96% The revenue of Medicamen Biotech Ltd for the Mar '25 is ₹ 34.84 crore as compare to the Dec '24 revenue of ₹ 45.28 crore. This represent the decline of -23.06%.
  • The ebitda of Hester Biosciences Ltd for the Mar '25 is ₹ 13.54 crore as compare to the Dec '24 ebitda of ₹ 13.85 crore. This represent the decline of -2.24% The ebitda of Medicamen Biotech Ltd for the Mar '25 is ₹ 3.62 crore as compare to the Dec '24 ebitda of ₹ 6.85 crore. This represent the decline of -47.15%.
  • The net profit of Hester Biosciences Ltd changed from ₹ 6.71 crore to ₹ 1.54 crore over 8 quarters. This represents a CAGR of -52.09% The net profit of Medicamen Biotech Ltd changed from ₹ 3.95 crore to ₹ 1.86 crore over 8 quarters. This represents a CAGR of -31.38% .
  • The Dividend Payout of Hester Biosciences Ltd changed from 17.99 % on March 2020 to 18.8 % on March 2024 . This represents a CAGR of 0.88% over 5 yearsThe Dividend Payout of Medicamen Biotech Ltd changed from 4.98 % on March 2020 to 9.56 % on March 2024 . This represents a CAGR of 13.93% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Hester Biosciences Ltd

  • Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
  • The Company was incorporated in April, 1987 and is principally engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company engages in two business verticals, namely Poultry Healthcare and Animal Healthcare.
  • It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
  • The products and services offered include over 51 vaccines and 70+ health products.
  • In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.

About Medicamen Biotech Ltd

  • A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
  • The Company has presence in 40+ countries.
  • Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
  • MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
  • The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

Hester Biosciences Ltd News Hub

News

Board of Hester Biosciences recommends final dividend

Hester Biosciences announced that the Board of Directors of the Company at its meeting hel...

Read more

09 May 2025 13:50

News

Hester Biosciences registers 30% YoY jump in Q4 PAT PAT to Rs 9.6 crore

The Animal Division, which includes both Ruminants and Pet health products, reported an 8%...

Read more

09 May 2025 13:56

News

Hester Biosciences to conduct board meeting

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 9 May 2...

Read more

02 May 2025 14:01

News

Hester Biosciences to declare Quarterly Result

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 30 Janu...

Read more

23 Jan 2025 09:45

News

Hester Biosciences receives reaffirmation in credit rating for bank facilities

Hester Biosciences has received reaffirmation in credit ratings for bank facilities at CAR...

Read more

20 Dec 2024 13:44

News

Hester Biosciences announces board meeting date

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 28 Octo...

Read more

21 Oct 2024 17:48

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech rallies after securing USFDA approval for Bortezomib injection

The ANDA pertains to Bortezomib for Injection, 3.5 mg single-dose vial. The USFDA has dete...

Read more

03 Jun 2025 13:07

News

Board of Medicamen Biotech recommends final dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

31 May 2025 12:29

News

Medicamen Biotech to hold board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

23 May 2025 20:27

News

Medicamen Biotech to convene EGM

Medicamen Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company wi...

Read more

27 Feb 2025 16:47

News

Medicamen Biotech announces board meeting date

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 26 Febru...

Read more

21 Feb 2025 19:50

News

Medicamen Biotech to declare Quarterly Results

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 11 Febru...

Read more

05 Feb 2025 14:45

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Hester Biosciences Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Medicamen Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Hester Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Hester Biosciences Ltd and Medicamen Biotech Ltd

Which company has a larger market capitalization, Hester Biosciences Ltd or Medicamen Biotech Ltd?

Market cap of Hester Biosciences Ltd is 1,486 Cr while Market cap of Medicamen Biotech Ltd is 547 Cr

What are the key factors driving the stock performance of Hester Biosciences Ltd and Medicamen Biotech Ltd?

The stock performance of Hester Biosciences Ltd and Medicamen Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hester Biosciences Ltd and Medicamen Biotech Ltd?

As of June 22, 2025, the Hester Biosciences Ltd stock price is INR ₹1747.2. On the other hand, Medicamen Biotech Ltd stock price is INR ₹403.45.

How do dividend payouts of Hester Biosciences Ltd and Medicamen Biotech Ltd compare?

To compare the dividend payouts of Hester Biosciences Ltd and Medicamen Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions